• Evaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa

    Recruiting

    2 1
    Investigated Diseases:
    Germany The Netherlands Poland Spain

  • Study of D-cycloserine with theta-burst brain stimulation for adults with major depressive disorder

    Recruiting

    2 1
    Investigated Diseases:
    Sweden

  • Study of Darbepoetin Alfa to Reduce Blood Transfusion Needs During Liver Transplant Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Spain

  • Study of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany

  • Study of brimonidine tartrate gel to prevent nerve damage in breast cancer patients receiving taxane treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of RVU120 treatment in patients with myelodysplastic syndrome, solid tumors, or acute myeloid leukemia who benefited from previous RVU120 therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Poland Spain

  • Study comparing diclofenac, orphenadrine and paracetamol combination versus diclofenac alone and orphenadrine-paracetamol combination in patients with acute low back pain

    Recruiting

    3 1 1
    Investigated Drugs:
    Greece

  • Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Bulgaria Finland France Germany Greece Hungary +7

  • Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy Poland Spain

  • Study of Clindamycin Use During Heart Surgery with Extracorporeal Circulation to Prevent Surgical Site Infections

    Recruiting

    2 1 1 1
    Investigated Drugs:
    France

powered by